Th17 Cells in Health and Disease
joint with The Biology of Cytokines
Organizer(s): Chen Dong, Vijay K. Kuchroo, Jay K. Kolls and Brigitta StockingerDate: February 05 - 10, 2012
Location: Keystone Resort, Keystone, CO, USA
Nearly five years ago, a new type of T cell, called the Th17 cell, was discovered. Th17 cells have unique regulation and have been shown to be associated with many types of immune diseases and cancer. Since the first Keystone Symposia meeting on Th17 cells in 2009, there has been rapid progress in our understanding of the roles of IL-17-producing T cells in innate immunity to infection, the plasticity of Th17 cell, and genetic diseases associated with Th17 defects. The goal of this second Keystone Symposia meeting on Th17 cells is to gather experts in basic and clinical research areas and provide a productively interactive forum to further our understanding of Th17 regulation and function in immune responses and diseases. Opportunities for interdisciplinary interactions will be significantly enhanced by the concurrent meeting on The Biology of Cytokines, which will share a keynote address and two plenary sessions with this meeting.
Scholarship Deadline: October 5 2011
Discounted Abstract Deadline: October 5 2011
Abstract Deadline: November 7 2011
Discounted Registration Deadline: December 5 2011
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
EMBO Young Investigator Programme
GlaxoSmithKline R&D China
We gratefully acknowledge the generous grant for this conference provided by:National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI098284-01
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.